echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAHA: Relationship between anxiety and pain medication and risk of post-traumatic stress disorder symptoms in patients with acute coronary syndrome

    JAHA: Relationship between anxiety and pain medication and risk of post-traumatic stress disorder symptoms in patients with acute coronary syndrome

    • Last Update: 2021-01-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Phenytropines and morphine are given during acute coronary syndrome (ACS) to relieve anxiety and pain, and β blockers can also relieve pain.
    ACS can induce post-traumatic stress disorder (PTSD) symptoms (PTSS).
    taking benzodiazepines during trauma rather than acute coronary syndrome increases the risk of ACS, it is not clear whether benzodiazepines increase the risk of PTSS in ACS patients.
    , researchers analyzed the effects of exposure to these drugs on the development of PTSS during ACS in a study published recently in JAHA, an authoritative journal for cardiovascular disease.
    study participants, 154 confirmed ACS patients, obtained baseline demographics, clinical variables, and psychodetic indicators through medical history, psychodegnostic assessment, and patient records, and used them as covariables in linear regression analysis.
    three months after using ACS, the researchers assessed the severity of PTSS in subjects using a clinician-administered PTSD scale.
    During ACS, 37.7 percent of patients were exposed to benzodiazepines, while 72.1 percent were exposed to morphine and 88.3 percent were exposed to β blockers, but only 7.1 percent were exposed to antidepressants.
    18 patients (11.7%) had clinical PTSD.
    adjustment of all covariates, the use of benzodiazepines was significantly related to the overall severity score of the clinician-administered PTSD scale (non-standardized coefficient B (SE) was 0.589 (0.274);
    the symptoms of acute stress disorder, the relative risk of clinical PTSD in patients exposed to benzodiazepines increased nearly fourfold (ratio ratio was 3.75; 95% confidence interval was 1.31-10.77).
    morphine, β, and antidepressants had no predicted value.
    , it can be seen that although benzodiazepines have short-term anti-anxiety effects during ACS, they may increase the risk of ACS-induced PTSS, which can affect the quality of life and prognostics of patients.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.